Accuracy of computer-aided chest X-ray in community-based tuberculosis screening: Lessons from the 2016 Kenya National Tuberculosis Prevalence Survey.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 07 01 2022
accepted: 18 10 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Community-based screening for tuberculosis (TB) could improve detection but is resource intensive. We set out to evaluate the accuracy of computer-aided TB screening using digital chest X-ray (CXR) to determine if this approach met target product profiles (TPP) for community-based screening. CXR images from participants in the 2016 Kenya National TB Prevalence Survey were evaluated using CAD4TBv6 (Delft Imaging), giving a probabilistic score for pulmonary TB ranging from 0 (low probability) to 99 (high probability). We constructed a Bayesian latent class model to estimate the accuracy of CAD4TBv6 screening compared to bacteriologically-confirmed TB across CAD4TBv6 threshold cut-offs, incorporating data on Clinical Officer CXR interpretation, participant demographics (age, sex, TB symptoms, previous TB history), and sputum results. We compared model-estimated sensitivity and specificity of CAD4TBv6 to optimum and minimum TPPs. Of 63,050 prevalence survey participants, 61,848 (98%) had analysable CXR images, and 8,966 (14.5%) underwent sputum bacteriological testing; 298 had bacteriologically-confirmed pulmonary TB. Median CAD4TBv6 scores for participants with bacteriologically-confirmed TB were significantly higher (72, IQR: 58-82.75) compared to participants with bacteriologically-negative sputum results (49, IQR: 44-57, p<0.0001). CAD4TBv6 met the optimum TPP; with the threshold set to achieve a mean sensitivity of 95% (optimum TPP), specificity was 83.3%, (95% credible interval [CrI]: 83.0%-83.7%, CAD4TBv6 threshold: 55). There was considerable variation in accuracy by participant characteristics, with older individuals and those with previous TB having lowest specificity. CAD4TBv6 met the optimal TPP for TB community screening. To optimise screening accuracy and efficiency of confirmatory sputum testing, we recommend that an adaptive approach to threshold setting is adopted based on participant characteristics.

Identifiants

pubmed: 36962655
doi: 10.1371/journal.pgph.0001272
pii: PGPH-D-22-00030
pmc: PMC10022380
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0001272

Informations de copyright

Copyright: © 2022 Mungai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2018 Dec 26;13(12):e0209098
pubmed: 30586448
Sci Rep. 2019 Oct 18;9(1):15000
pubmed: 31628424
Trop Med Int Health. 2020 Nov;25(11):1308-1327
pubmed: 32910557
J Bras Pneumol. 2012 Sep-Oct;38(5):656-65
pubmed: 23147059
Lancet Public Health. 2021 May;6(5):e283-e299
pubmed: 33765456
Lancet Digit Health. 2020 Nov;2(11):e573-e581
pubmed: 33328086
PLoS One. 2014 Apr 04;9(4):e93757
pubmed: 24705629
PLoS One. 2019 Sep 3;14(9):e0221339
pubmed: 31479448
Eur Respir J. 2017 May 21;49(5):
pubmed: 28529204
PLoS Med. 2021 Sep 9;18(9):e1003752
pubmed: 34499665
BMC Med. 2020 May 11;18(1):119
pubmed: 32389127
Thorax. 2021 Jun;76(6):607-614
pubmed: 33504563
Int J Tuberc Lung Dis. 2005 Nov;9(11):1183-203
pubmed: 16333924
Lancet Digit Health. 2021 Sep;3(9):e543-e554
pubmed: 34446265
Clin Infect Dis. 2021 Aug 2;73(3):e830-e841
pubmed: 32936877
Sci Rep. 2015 Jul 27;5:12215
pubmed: 26212560
Int J Infect Dis. 2021 Dec;113 Suppl 1:S7-S12
pubmed: 33716195
Clin Infect Dis. 1997 Aug;25(2):242-6
pubmed: 9332519
BMC Infect Dis. 2005 Dec 12;5:111
pubmed: 16343340
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
Sci Rep. 2020 Mar 26;10(1):5492
pubmed: 32218458
PLoS One. 2014 Sep 05;9(9):e106381
pubmed: 25192172

Auteurs

Brenda Mungai (B)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
African Institute for Development Policy, Nairobi, Kenya.
Centre for Health Solutions, Nairobi, Kenya.

Jane Ong'angò (J)

Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Chu Chang Ku (CC)

Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.

Marc Y R Henrion (MYR)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Ben Morton (B)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Critical Care Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Elizabeth Joekes (E)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Worldwide Radiology, Liverpool, United Kingdom.

Elizabeth Onyango (E)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Richard Kiplimo (R)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Dickson Kirathe (D)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Enos Masini (E)

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Stop TB Partnership, Le Grand-Saconnex, Switzerland.

Joseph Sitienei (J)

Division of National Tuberculosis, Leprosy and Lung Disease Program, Nairobi, Kenya.

Veronica Manduku (V)

Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Beatrice Mugi (B)

Kenyatta National Hospital, Nairobi, Kenya.

Stephen Bertel Squire (SB)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Tropical & Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Peter MacPherson (P)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Clinical Research Department, London School of Hygiene and Tropical Medicine, Liverpool, United Kingdom.

Classifications MeSH